{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:35:53Z","timestamp":1786736153912,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Trichol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijt.ijt_22_19","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T05:31:45Z","timestamp":1566192705000},"page":"173","source":"Crossref","is-referenced-by-count":4,"title":["Alopecia universalis in a case of rheumatoid arthritis after treatment with etanercept"],"prefix":"10.4103","volume":"11","author":[{"given":"Renu","family":"Kandpal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-7753.264713-1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/ijt.ijt_99_17","article-title":"Alopecia areata: Review of epidemiology, clinical features, pathogenesis, and new treatment options","author":"Darwin","year":"2018","journal-title":"Int J Trichology"},{"key":"key-10.4103\/0974-7753.264713-2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archderm.1992.01680150136027","article-title":"Prevalence of alopecia areata in the first national health and nutrition examination survey","author":"Safavi","year":"1992","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0974-7753.264713-3","first-page":"373","article-title":"The genetic risk for alopecia areata in first degree relatives of severely affected patients.An estimate","author":"van","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0974-7753.264713-4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/sj.jidsp.5640214","article-title":"The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis","author":"Colombe","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"key-10.4103\/0974-7753.264713-5","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/art.24672","article-title":"Genetic susceptibility to rheumatoid arthritis: An emerging picture","author":"Barton","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0974-7753.264713-6","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-7753.264713-7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3346\/jkms.2012.27.7.799","article-title":"Clinical characteristics and prognostic factors in early-onset al opecia totalis and alopecia universalis","author":"Cho","year":"2012","journal-title":"J Korean Med Sci"},{"key":"key-10.4103\/0974-7753.264713-8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","article-title":"The autoimmune basis of alopecia areata: A comprehensive review","author":"Islam","year":"2015","journal-title":"Autoimmun Rev"},{"key":"key-10.4103\/0974-7753.264713-9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","article-title":"Alopecia areata update: Part I.Clinical picture, histopathology, and pathogenesis","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.264713-10","doi-asserted-by":"crossref","first-page":"e94260","DOI":"10.1371\/journal.pone.0094260","article-title":"Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata","author":"Bertolini","year":"2014","journal-title":"PLoS One"},{"key":"key-10.4103\/0974-7753.264713-11","first-page":"541","article-title":"Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?","author":"Paus","year":"1993","journal-title":"Yale J Biol Med"},{"key":"key-10.4103\/0974-7753.264713-12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9440(10)63151-3","article-title":"Collapse and restoration of MHC class-I-dependent immune privilege: Exploiting the human hair follicle as a model","author":"Ito","year":"2004","journal-title":"Am J Pathol"},{"key":"key-10.4103\/0974-7753.264713-13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0733-8635(05)70392-2","article-title":"The pathogenesis of alopecia areata","author":"McDonagh","year":"1996","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0974-7753.264713-14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","author":"Gabriel","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"key-10.4103\/0974-7753.264713-15","first-page":"450","article-title":"Alopecia areata during treatment with adalimumab: Therapy with an alternative TNF-alpha inhibitor is possible","author":"Zschoche","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"key-10.4103\/0974-7753.264713-16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1590\/abd1806-4841.20142944","article-title":"Alopecia universalis during treatment with leflunomide and adalimumab \u2013 Case report","author":"Lazzarini","year":"2014","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/0974-7753.264713-17","first-page":"759","article-title":"Recurrence of alopecia areata in a patient receiving etanercept injections","author":"Posten","year":"2005","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0974-7753.264713-18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaad.2005.03.039","article-title":"Etanercept does not effectively treat moderate to severe alopecia areata: An open-label study","author":"Strober","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.264713-19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000113945","article-title":"Alopecia areata universalis elicited during treatment with adalimumab","author":"Pelivani","year":"2008","journal-title":"Dermatology"},{"key":"key-10.4103\/0974-7753.264713-20","first-page":"1653","article-title":"Alopecia areata during treatment with biologic agents","author":"Tosti","year":"2006","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0974-7753.264713-21","first-page":"1654","article-title":"Development of alopecia areata universalis in a patient receiving adalimumab","author":"Garcia","year":"2006","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0974-7753.264713-22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000335264","article-title":"Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: A case and review of the literature","author":"Navarro","year":"2012","journal-title":"Skin Pharmacol Physiol"},{"key":"key-10.4103\/0974-7753.264713-23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00393-018-0464-z","article-title":"Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab","author":"Ostojic","year":"2018","journal-title":"Z Rheumatol"}],"container-title":["International Journal of Trichology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:38:02Z","timestamp":1786732682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_22_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["264713"],"URL":"https:\/\/doi.org\/10.4103\/ijt.ijt_22_19","relation":{},"ISSN":["0974-7753"],"issn-type":[{"value":"0974-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}